NYSE:SYK - Stryker Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $256.00
  • Forecasted Upside: 14.73 %
  • Number of Analysts: 15
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 10 Buy Ratings
  • 0 Strong Buy Ratings
$223.14
▲ +5.13 (2.35%)

This chart shows the closing price for SYK by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Stryker Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SYK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SYK

Analyst Price Target is $256.00
▲ +14.73% Upside Potential
This price target is based on 15 analysts offering 12 month price targets for Stryker in the last 3 months. The average price target is $256.00, with a high forecast of $305.00 and a low forecast of $205.00. The average price target represents a 14.73% upside from the last price of $223.14.

This chart shows the closing price for SYK for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 15 investment analysts is to buy stock in Stryker. This rating has held steady since July 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 11 buy ratings
  • 8 hold ratings
  • 2 sell ratings
2/18/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 8 hold ratings
  • 0 sell ratings
5/19/2021
  • 0 strong buy ratings
  • 13 buy ratings
  • 7 hold ratings
  • 1 sell ratings
8/17/2021
  • 0 strong buy ratings
  • 13 buy ratings
  • 6 hold ratings
  • 1 sell ratings
11/15/2021
  • 0 strong buy ratings
  • 14 buy ratings
  • 6 hold ratings
  • 1 sell ratings
2/13/2022
  • 0 strong buy ratings
  • 12 buy ratings
  • 6 hold ratings
  • 1 sell ratings
5/14/2022
  • 0 strong buy ratings
  • 12 buy ratings
  • 6 hold ratings
  • 0 sell ratings
7/13/2022
  • 0 strong buy ratings
  • 10 buy ratings
  • 5 hold ratings
  • 0 sell ratings
8/12/2022

Latest Recommendations

  • 0 strong buy ratings
  • 10 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/28/2022Edward JonesUpgradeHold ➝ BuyLow
7/27/2022Truist FinancialBoost Price TargetOutperform$220.00Low
7/27/2022Robert W. BairdLower Price TargetOutperform ➝ Outperform$297.00 ➝ $240.00Low
7/27/2022Piper SandlerLower Price TargetOverweight$290.00 ➝ $250.00Low
7/22/2022Truist FinancialLower Price Target$213.00Low
7/22/2022CowenLower Price TargetOutperform$305.00 ➝ $233.00Low
7/21/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$285.00 ➝ $205.00Low
7/18/2022BTIG ResearchLower Price TargetBuy$278.00 ➝ $244.00Low
7/18/2022Stifel NicolausLower Price Target$285.00 ➝ $245.00Low
7/15/2022Morgan StanleyLower Price TargetEqual Weight$270.00 ➝ $220.00Low
7/11/2022Bank of AmericaDowngradeBuy ➝ NeutralN/A
5/17/2022CitigroupLower Price Target$310.00 ➝ $280.00N/A
5/2/2022Truist FinancialLower Price Target$296.00 ➝ $280.00Low
4/29/2022Piper SandlerLower Price Target$315.00 ➝ $290.00High
4/18/2022BTIG ResearchBoost Price Target$273.00 ➝ $278.00Low
4/12/2022Truist FinancialInitiated CoverageHold$296.00Low
3/16/2022Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$288.00 ➝ $295.00Medium
3/15/2022Evercore ISIReiterated RatingOutperform$284.00High
3/1/2022Bank of AmericaInitiated CoverageBuy ➝ BuyHigh
1/31/2022Morgan StanleyLower Price TargetEqual Weight$305.00 ➝ $275.00Low
1/28/2022SVB LeerinkLower Price TargetOutperform$300.00 ➝ $285.00High
1/28/2022BTIG ResearchLower Price TargetBuy$280.00 ➝ $273.00High
1/28/2022CitigroupLower Price Target$300.00 ➝ $290.00High
1/7/2022Morgan StanleyDowngradeOverweight ➝ Equal Weight$305.00High
1/4/2022Piper SandlerUpgradeNeutral ➝ Overweight$250.00 ➝ $315.00High
12/9/2021Royal Bank of CanadaInitiated CoverageSector Perform$278.00Low
12/6/2021Loop CapitalInitiated CoverageBuy$305.00High
11/19/2021Morgan StanleyBoost Price TargetOverweight$295.00 ➝ $305.00High
10/29/2021Robert W. BairdReiterated RatingBuy$301.00Medium
10/29/2021Piper SandlerBoost Price TargetNeutral$250.00 ➝ $255.00High
10/22/2021SVB LeerinkReiterated RatingOutperformMedium
9/14/2021Raymond JamesInitiated CoverageMarket PerformMedium
7/29/2021ArgusBoost Price TargetBuy$280.00 ➝ $320.00Low
7/28/2021Truist FinancialBoost Price TargetHold$250.00 ➝ $275.00Medium
7/28/2021Morgan StanleyBoost Price TargetOverweight$280.00 ➝ $300.00Low
7/28/2021SVB LeerinkBoost Price TargetOutperform$290.00 ➝ $300.00Low
7/28/2021Credit Suisse GroupBoost Price TargetOutperform$291.00 ➝ $311.00Low
7/28/2021OppenheimerBoost Price TargetMarket Perform$273.00 ➝ $288.00Low
7/28/2021Northland SecuritiesUpgradeMarket Perform ➝ Outperform$248.00 ➝ $310.00Low
7/28/2021Needham & Company LLCReiterated RatingHoldMedium
7/28/2021Robert W. BairdBoost Price TargetOutperform$292.00 ➝ $305.00Medium
7/28/2021CitigroupBoost Price TargetBuy$303.00 ➝ $310.00Medium
7/28/2021Piper SandlerBoost Price TargetNeutral$250.00 ➝ $255.00Medium
7/20/2021SVB LeerinkReiterated RatingOutperformMedium
6/28/2021Credit Suisse GroupReiterated RatingBuy$291.00Low
6/1/2021Evercore ISIUpgradeIn-Line ➝ Outperform$260.00 ➝ $285.00High
5/24/2021BarclaysInitiated CoverageUnderweight$280.00Low
4/28/2021OppenheimerBoost Price Target$240.00 ➝ $273.00High
4/28/2021Truist FinancialBoost Price Target$245.00 ➝ $255.00High
4/28/2021CitigroupBoost Price Target$264.00 ➝ $303.00High
4/28/2021Morgan StanleyBoost Price TargetOverweight$265.00 ➝ $280.00Medium
4/28/2021Wells Fargo & CompanyBoost Price TargetOverweight$265.00 ➝ $300.00High
4/28/2021Raymond JamesBoost Price TargetOutperform$255.00 ➝ $290.00Medium
4/28/2021CowenBoost Price TargetOutperform$255.00 ➝ $279.00High
4/28/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$251.00 ➝ $285.00High
4/28/2021Robert W. BairdBoost Price TargetOutperform$265.00 ➝ $292.00High
2/24/2021JPMorgan Chase & Co.Boost Price TargetOverweight$245.00 ➝ $265.00Low
1/28/2021Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$278.00 ➝ $273.00Low
1/28/2021Morgan StanleyLower Price TargetOverweight$272.00 ➝ $265.00High
1/28/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$228.00 ➝ $251.00Low
1/28/2021Raymond JamesBoost Price TargetOutperform$240.00 ➝ $255.00Low
1/28/2021Needham & Company LLCReiterated RatingHoldLow
1/6/2021Truist FinancialBoost Price Target$210.00 ➝ $245.00N/A
1/6/2021Credit Suisse GroupBoost Price TargetOutperform$253.00 ➝ $278.00N/A
1/4/2021GuggenheimInitiated CoverageNeutralN/A
12/31/2020BTIG ResearchBoost Price TargetBuy$234.00 ➝ $252.00N/A
12/15/2020Morgan StanleyBoost Price TargetOverweight$225.00 ➝ $272.00Low
11/12/2020Robert W. BairdBoost Price TargetOutperform$243.00 ➝ $258.00Low
10/30/2020Smith Barney CitigroupBoost Price Target$232.00 ➝ $240.00High
10/30/2020SVB LeerinkBoost Price TargetOutperform$225.00 ➝ $235.00High
10/30/2020Credit Suisse GroupBoost Price TargetOutperform$243.00 ➝ $253.00High
10/12/2020Raymond JamesBoost Price TargetOutperform$220.00 ➝ $240.00Medium
10/6/2020Northland SecuritiesInitiated CoverageMarket Perform$225.00Medium
9/28/2020Wells Fargo & CompanyBoost Price TargetOverweight$222.00 ➝ $232.00Medium
9/11/2020Wolfe ResearchInitiated CoverageMarket Perform$230.00Low
7/31/2020UBS GroupBoost Price TargetNeutral$202.00 ➝ $215.00High
7/31/2020Morgan StanleyBoost Price TargetOverweight$215.00 ➝ $225.00Low
7/31/2020SVB LeerinkBoost Price TargetOutperform$215.00 ➝ $225.00Medium
7/31/2020Credit Suisse GroupBoost Price TargetOutperform$237.00 ➝ $243.00High
7/31/2020Needham & Company LLCReiterated RatingHoldMedium
7/31/2020OppenheimerReiterated RatingHold$215.00Medium
7/31/2020CitigroupBoost Price TargetBuy$227.00 ➝ $232.00Medium
7/15/2020SVB LeerinkReiterated RatingOutperformLow
5/11/2020ArgusLower Price TargetBuy$240.00 ➝ $230.00Low
5/1/2020CitigroupBoost Price TargetBuy$200.00 ➝ $215.00Medium
5/1/2020CfraLower Price TargetStrong-Buy$234.00 ➝ $231.00Low
5/1/2020Wells Fargo & CompanyBoost Price TargetOverweight$201.00 ➝ $205.00Medium
5/1/2020Morgan StanleyBoost Price TargetOverweight$210.00 ➝ $215.00High
5/1/2020Stifel NicolausBoost Price TargetBuy$145.00 ➝ $205.00High
5/1/2020UBS GroupLower Price TargetNeutral$230.00 ➝ $202.00High
5/1/2020OppenheimerReiterated RatingHold$200.00Medium
5/1/2020Credit Suisse GroupBoost Price TargetOutperform$229.00 ➝ $237.00Medium
5/1/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$243.00 ➝ $228.00High
4/22/2020CowenLower Price TargetOutperform$240.00 ➝ $220.00Low
4/15/2020JPMorgan Chase & Co.Lower Price TargetOverweight$240.00 ➝ $210.00Medium
4/13/2020Raymond JamesLower Price TargetOutperform$240.00 ➝ $205.00High
4/13/2020BarclaysDowngradeEqual Weight ➝ Underweight$155.00High
4/1/2020Wells Fargo & CompanyLower Price TargetOverweight$243.00 ➝ $201.00Medium
4/1/2020The Goldman Sachs GroupDowngradeBuy ➝ Sell$248.00 ➝ $150.00High
3/27/2020Morgan StanleyLower Price TargetOverweight$250.00 ➝ $210.00Low
3/27/2020CitigroupLower Price TargetBuy$235.00 ➝ $200.00Medium
3/25/2020Credit Suisse GroupLower Price TargetOutperform$247.00 ➝ $162.00Low
3/24/2020Stifel NicolausLower Price TargetBuy$250.00 ➝ $145.00High
3/6/2020Credit Suisse GroupLower Price TargetOutperform$255.00 ➝ $247.00Low
3/4/2020CitigroupInitiated CoverageBuy$235.00High
2/12/2020The Goldman Sachs GroupInitiated CoverageBuy$248.00Low
1/30/2020BTIG ResearchReiterated RatingBuyMedium
1/29/2020Cantor FitzgeraldReiterated RatingNeutralMedium
1/29/2020Stifel NicolausBoost Price TargetBuy$245.00 ➝ $250.00Low
1/29/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$239.00 ➝ $243.00Low
1/29/2020Robert W. BairdBoost Price TargetOutperform$242.00 ➝ $248.00High
1/29/2020Morgan StanleyBoost Price TargetOverweight$242.00 ➝ $250.00High
1/7/2020SunTrust BanksInitiated CoverageHold$217.00Low
1/7/2020Piper SandlerDowngradeOverweight ➝ Neutral$210.00Low
1/7/2020Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$210.00Medium
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$179.00Low
1/2/2020Evercore ISIUpgradeIn-Line ➝ OutperformLow
12/30/2019BTIG ResearchBoost Price TargetBuy$228.00 ➝ $236.00Low
12/17/2019Morgan StanleyBoost Price TargetOverweight$230.00 ➝ $242.00High
11/5/2019BarclaysDowngradeOverweight ➝ Equal Weight$226.00 ➝ $207.00High
10/30/2019Robert W. BairdBoost Price TargetOutperform$239.00 ➝ $242.00Medium
10/30/2019Bank of AmericaBoost Price TargetBuy$220.00 ➝ $245.00High
9/5/2019BTIG ResearchSet Price TargetBuy$228.00Medium
9/4/2019Piper Jaffray CompaniesReiterated RatingBuyLow
7/29/2019BTIG ResearchReiterated RatingBuy$228.00Low
7/26/2019Raymond JamesSet Price TargetBuy$240.00Low
7/26/2019Royal Bank of CanadaSet Price TargetBuy$220.00Low
7/26/2019BMO Capital MarketsSet Price TargetHold$216.00Low
7/26/2019BarclaysSet Price TargetBuy$226.00N/A
7/26/2019Robert W. BairdBoost Price TargetOutperform$206.00 ➝ $239.00Low
7/26/2019Credit Suisse GroupBoost Price TargetOutperform$232.00 ➝ $237.00Low
7/26/2019Cantor FitzgeraldBoost Price TargetNeutral$190.00 ➝ $230.00High
7/26/2019Piper Jaffray CompaniesBoost Price TargetOverweight$205.00 ➝ $240.00High
7/16/2019Morgan StanleyBoost Price TargetOverweight$218.00 ➝ $230.00Low
7/15/2019BTIG ResearchBoost Price TargetBuy ➝ Positive$219.00Medium
7/11/2019Credit Suisse GroupBoost Price TargetOutperform$200.00 ➝ $232.00Low
7/10/2019SVB LeerinkReiterated RatingOutperformLow
7/2/2019Wells Fargo & CompanyBoost Price TargetOutperform$219.00 ➝ $228.00Low
4/24/2019OppenheimerBoost Price TargetOutperform$183.00 ➝ $192.00Low
4/24/2019Robert W. BairdBoost Price TargetOutperform ➝ Outperform$201.00 ➝ $206.00Low
4/24/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$181.00 ➝ $208.00Low
4/24/2019Cantor FitzgeraldBoost Price TargetNeutral ➝ Neutral$175.00 ➝ $190.00Low
4/15/2019BarclaysBoost Price TargetOverweight ➝ Overweight$203.00 ➝ $211.00Low
4/1/2019Wells Fargo & CompanyBoost Price TargetOutperform$214.00 ➝ $219.00Low
3/19/2019JPMorgan Chase & Co.Boost Price TargetOverweight$200.00 ➝ $215.00Medium
3/18/2019BTIG ResearchBoost Price TargetBuy$211.00Low
3/11/2019Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$184.00 ➝ $204.00Medium
3/8/2019BarclaysSet Price TargetBuy$203.00Low
3/4/2019Morgan StanleyBoost Price TargetOverweight ➝ Overweight$200.00 ➝ $218.00Low
3/1/2019Piper Jaffray CompaniesReiterated RatingOverweight$205.00Medium
2/4/2019SunTrust BanksBoost Price TargetBuy ➝ Positive$205.00Low
1/31/2019Credit Suisse GroupUpgradeOutperformMedium
1/18/2019Cantor FitzgeraldReiterated RatingNeutralMedium
1/2/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$179.00Medium
1/2/2019Morgan StanleyLower Price TargetOverweight ➝ Overweight$212.00 ➝ $197.00Low
1/2/2019CitigroupLower Price TargetNeutral ➝ Neutral$174.00 ➝ $169.00Low
1/2/2019Evercore ISIUpgradeIn-Line ➝ Outperform$156.75Medium
12/17/2018Credit Suisse GroupInitiated CoverageOutperform$195.00Low
11/27/2018UBS GroupInitiated CoverageNeutral$180.00 ➝ $180.00High
11/15/2018CitigroupBoost Price TargetNeutral ➝ Neutral$173.00 ➝ $174.00Medium
11/9/2018OppenheimerSet Price TargetHold$170.00N/A
11/9/2018CowenSet Price TargetBuy$195.00Low
11/9/2018Needham & Company LLCReiterated RatingHoldLow
10/26/2018OppenheimerSet Price TargetHold$170.00Medium
10/15/2018BarclaysInitiated CoverageOverweight ➝ Overweight$198.00High
9/13/2018JPMorgan Chase & Co.Boost Price TargetOverweight$200.00Medium
9/12/2018BTIG ResearchReiterated RatingBuy$187.00Low
9/11/2018Needham & Company LLCReiterated RatingHoldLow
8/16/2018BTIG ResearchInitiated CoverageBuy$187.00Medium
7/25/2018OppenheimerSet Price TargetHold$170.00Medium
7/25/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$187.00 ➝ $192.00Medium
7/25/2018CitigroupBoost Price TargetNeutral ➝ Neutral$171.00 ➝ $173.00High
7/25/2018Cantor FitzgeraldBoost Price TargetNeutral ➝ Neutral$170.00 ➝ $175.00High
7/25/2018Royal Bank of CanadaReiterated RatingBuy$184.00High
7/25/2018Needham & Company LLCReiterated RatingHoldHigh
7/12/2018BMO Capital MarketsReiterated RatingHold$174.00Low
6/27/2018Sanford C. BernsteinInitiated CoverageMarket Perform$177.00Medium
6/13/2018Cantor FitzgeraldReiterated RatingHold$170.00Low
5/1/2018CitigroupBoost Price TargetNeutral ➝ Neutral$166.00 ➝ $171.00Low
4/27/2018BMO Capital MarketsBoost Price TargetMarket Perform$170.00Medium
4/27/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$183.00 ➝ $187.00Low
4/27/2018Cantor FitzgeraldReiterated RatingHold ➝ NeutralHigh
4/2/2018Evercore ISIInitiated CoverageIn-Line$165.00Medium
3/15/2018Raymond JamesInitiated CoverageOutperform$183.00Low
2/27/2018CitigroupUpgradeSell ➝ Neutral$165.77 ➝ $166.00Medium
2/26/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$179.00 ➝ $186.00High
2/1/2018OppenheimerReiterated RatingHold$165.00Low
2/1/2018CitigroupReiterated RatingMarket Perform$156.00 ➝ $165.00Low
1/31/2018GuggenheimReiterated RatingBuyLow
1/31/2018Piper Jaffray CompaniesReiterated RatingBuy$170.00Low
1/31/2018Needham & Company LLCReiterated RatingHoldMedium
1/31/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$177.00 ➝ $184.00Low
1/30/2018Cantor FitzgeraldReiterated RatingHold$163.00Medium
1/26/2018SunTrust BanksReiterated RatingBuy ➝ Buy$161.00 ➝ $179.00Low
1/17/2018Needham & Company LLCReiterated RatingHoldLow
1/9/2018Royal Bank of CanadaReiterated RatingBuy$175.00Low
1/9/2018Piper Jaffray CompaniesBoost Price TargetOverweight ➝ Overweight$156.00 ➝ $166.00Low
1/5/2018Cantor FitzgeraldReiterated RatingNeutral ➝ Neutral$163.00Medium
1/2/2018Wells Fargo & CompanyReiterated RatingOutperform$166.00 ➝ $174.00Medium
1/2/2018JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightMedium
12/12/2017BMO Capital MarketsUpgradeMarket Perform$163.00Low
12/7/2017Needham & Company LLCReiterated RatingHoldLow
11/24/2017Robert W. BairdUpgradeNeutral ➝ OutperformN/A
11/17/2017SunTrust BanksReiterated RatingBuy$161.00N/A
11/16/2017Robert W. BairdUpgradeNeutral ➝ Outperform$161.00 ➝ $173.00N/A
11/3/2017Needham & Company LLCReiterated RatingHoldN/A
10/30/2017OppenheimerSet Price TargetHold$148.00 ➝ $156.00N/A
10/29/2017CowenSet Price TargetBuy$166.00N/A
10/27/2017BarclaysBoost Price TargetUnderweight$137.00 ➝ $148.00N/A
10/27/2017Stifel NicolausBoost Price TargetBuy$158.00 ➝ $168.00N/A
10/27/2017Wells Fargo & CompanyBoost Price Target$160.00 ➝ $166.00N/A
10/27/2017Piper Jaffray CompaniesReiterated RatingBuy$156.00N/A
10/27/2017Robert W. BairdReiterated RatingHold$161.00N/A
10/6/2017CowenSet Price TargetBuy$160.00N/A
10/2/2017Royal Bank of CanadaReiterated RatingBuy$155.00Low
10/2/2017SunTrust BanksReiterated RatingBuy$161.00Medium
9/1/2017Royal Bank of CanadaReiterated RatingBuy$155.00N/A
8/29/2017ArgusReiterated RatingBuy$160.00Low
8/25/2017Needham & Company LLCUpgradeUnderperform ➝ HoldLow
8/24/2017Piper Jaffray CompaniesReiterated RatingOverweight$148.00Low
8/23/2017OppenheimerReiterated RatingHoldLow
(Data available from 8/12/2017 forward)

News Sentiment Rating

-0.07 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 16 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
1/14/2022
  • 6 very positive mentions
  • 30 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
2/13/2022
  • 2 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/15/2022
  • 3 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
4/14/2022
  • 3 very positive mentions
  • 36 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
5/14/2022
  • 1 very positive mentions
  • 17 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
6/13/2022
  • 6 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
7/13/2022
  • 2 very positive mentions
  • 39 positive mentions
  • 18 negative mentions
  • 1 very negative mentions
8/12/2022

Current Sentiment

  • 2 very positive mentions
  • 39 positive mentions
  • 18 negative mentions
  • 1 very negative mentions
Stryker logo
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Read More

Today's Range

Now: $223.14
Low: $218.60
High: $223.32

50 Day Range

MA: $206.11
Low: $189.27
High: $230.70

52 Week Range

Now: $223.14
Low: $188.84
High: $281.16

Volume

39,927 shs

Average Volume

1,789,794 shs

Market Capitalization

$84.38 billion

P/E Ratio

41.09

Dividend Yield

1.27%

Beta

1.03

Frequently Asked Questions

What sell-side analysts currently cover shares of Stryker?

The following sell-side analysts have issued reports on Stryker in the last year: Bank of America Co., BTIG Research, Citigroup Inc., Cowen Inc., Deutsche Bank Aktiengesellschaft, Edward Jones, Evercore ISI, Loop Capital, Morgan Stanley, Piper Sandler, Raymond James, Robert W. Baird, Royal Bank of Canada, Sanford C. Bernstein, Stifel Nicolaus, StockNews.com, SVB Leerink LLC, TheStreet, and Truist Financial Co..
View the latest analyst ratings for SYK.

What is the current price target for Stryker?

14 Wall Street analysts have set twelve-month price targets for Stryker in the last year. Their average twelve-month price target is $256.00, suggesting a possible upside of 17.4%. Loop Capital has the highest price target set, predicting SYK will reach $305.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of $205.00 for Stryker in the next year.
View the latest price targets for SYK.

What is the current consensus analyst rating for Stryker?

Stryker currently has 5 hold ratings and 10 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SYK will outperform the market and that investors should add to their positions of Stryker.
View the latest ratings for SYK.

What other companies compete with Stryker?

How do I contact Stryker's investor relations team?

Stryker's physical mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company's listed phone number is (269) 385-2600 and its investor relations email address is [email protected] The official website for Stryker is www.strykercorp.com. Learn More about contacing Stryker investor relations.